title: Regulation of the corpus luteum by protein kinase C. II. Inhibition of lipoprotein-stimulated steroidogenesis by prostaglandin F2 alpha.
abstract: This study was designed to examine the antisteroidogenic action of prostaglandin (PG) F2 alpha on ovine luteal cells in vitro. Purified populations of large and small steroidogenic luteal cells were treated with lipoproteins, luteinizing hormone (LH), and/or PGF2 alpha. To investigate the involvement of the protein kinase C (PKC) pathway in hormone action, luteal cells were made PKC-deficient by treatment for 12 h with 1 microM phorbol-12-myristate-13-acetate. Progesterone production by nonstimulated large and LH-stimulated small luteal cells was significantly increased by treatment with high- and low-density lipoprotein (HDL, 5-fold increase; LDL, 2-fold increase). PGF2 alpha inhibited (p less than 0.0001) progesterone production by HDL-stimulated large luteal cells in a dose-dependent manner, with 60 nM causing maximal inhibition. No effect of PGF2 alpha (20nM-20 microM) was found on production of progesterone by HDL-stimulated, PKC-deficient large cells or by LH- and HDL-stimulated small luteal cells. These results suggest that PGF2 alpha has a direct antisteroidogenic effect on the large luteal cell that is mediated through the PKC second messenger pathway.
authors.affiliation: Department of Physiology, Colorado State University, Fort Collins 80523.
authors.forename: M C
authors.initials: MC
authors.lastname: Wiltbank
authors.forename: M G
authors.initials: MG
authors.lastname: Diskin
authors.forename: J A
authors.initials: JA
authors.lastname: Flores
authors.forename: G D
authors.initials: GD
authors.lastname: Niswender
mesh_terms: D000818:Animals; D002469:Cell Separation; D003338:Corpus Luteum / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D015237:Dinoprost / Q000494:pharmacology / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D008075:Lipoproteins, HDL / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000494:pharmacology; D011374:Progesterone / Q000378:metabolism; D011493:Protein Kinase C / Q000494:pharmacology / Q000502:physiology*; D015290:Second Messenger Systems / Q000187:drug effects / Q000502:physiology; D012756:Sheep
chemical_list: D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D011374:Progesterone; D015237:Dinoprost; D011493:Protein Kinase C